Transaction DateRecipientSharesTypePriceValue
1st October 2020Charles J Casamento3,000Open or private sale$37.99$113,955.60
1st September 2020Charles J Casamento3,000Open or private sale$34.74$104,206.80
18th August 2020Charles J Casamento26,362Exercise of derivative$3.24$85,412.88
18th August 2020Charles J Casamento2,189Payment by withholding$39.03$85,436.67
3rd August 2020Charles J Casamento3,000Open or private sale$35.74$107,213.40
1st July 2020Charles J Casamento3,000Open or private sale$43.89$131,677.20
19th March 2020Charles J Casamento9,000Bona fide gift$0.00
19th March 2020Charles J Casamento9,000Bona fide gift$0.00
17th March 2020Charles J Casamento21,484Bona fide gift$0.00
17th March 2020Charles J Casamento21,484Bona fide gift$0.00
Azur Rx Bio Pharma
Azur Rx Bio Pharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.


AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.


Ticker: AZRX
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1604191
Employees: 12
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals